Evidence map›Paper›PMID 28487610›Full record

Observational studyWorld journal of gastroenterology2017

Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).

Isabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, Luis Bujanda, Iñaki Gutierrez-Ibarluzea

Registry-linked trialOpen access · hybridAbstract readComparative StudyObservational Study
In one paragraph

Observational study in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05163236 (Sensitivity of Fecal Immunochemical Test), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05163236 completednot on this mapstarted 2021, after this paper: background citation

Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening and Interval Cancer Risk : a Population Based Study

TypeobservationalSponsorUniversity Hospital, BrestRan2021 to 2021Enrolled1,149ConditionsColorectal Neoplasms Malignant, Colonoscopy, Early Detection of Cancer, FemaleArmsPositive fecal immunochemical test (FIT), Negative fecal immunochemical test (FIT), Fecal immunochemical test (FIT) not performed
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Current and future colorectal cancer screening strategies.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Temporal Trends in Fecal Occult Blood Test: Associated Factors (2009-2017).International journal of environmental research and public health · 2019
    Article
  16. Contribution of the OC SensorEuropean journal of epidemiology · 2019
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Isabel PortilloIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
Eunate Arana-ArriIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
Isabel IdigorasIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
Isabel BilbaoIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
Lorea Martínez-IndartIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
Luis BujandaIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
Iñaki Gutierrez-IbarluzeaIsabel Portillo, Eunate Arana-Arri, Isabel Idigoras, Isabel Bilbao, Lorea Martínez-Indart, BioCruces Health Research Institute, Plaza de Cruces, 48903 Barakaldo, Spain.
BioCruces Health research Institute · ESOsakidetza · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess proportions, related conditions and survival of interval cancer (IC).

methodsThe programme has a linkage with different clinical databases and cancer registers to allow suitable evaluation. This evaluation involves the detection of ICs after a negative faecal inmunochemical test (FIT), interval cancer FIT (IC-FIT) prior to a subsequent invitation, and the detection of ICs after a positive FIT and confirmatory diagnosis without colorectal cancer (CRC) detected and before the following recommended colonoscopy, IC-colonoscopy. We conducted a retrospective observational study analyzing from January 2009 to December 2015 1193602 invited people onto the Programme (participation rate of 68.6%).

resultsTwo thousand five hundred and eighteen cancers were diagnosed through the programme, 18 cases of IC-colonoscopy were found before the recommended follow-up (43542 colonoscopies performed) and 186 IC-FIT were identified before the following invitation of the 769200 negative FITs. There was no statistically significant relation between the predictor variables of ICs with sex, age and deprivation index, but there was relation between location and stage. Additionally, it was observed that there was less risk when the location was distal rather than proximal (OR = 0.28, 95%CI: 0.20-0.40,

conclusionThese findings in a Population Based CRC Screening Programme indicate the need of population-based studies that continue analyzing related factors to improve their detection and reducing harm.

Indexed as

AgedColonoscopyColorectal NeoplasmsFecesFemaleHumansImmunologic TestsMaleMass ScreeningMiddle AgedRetrospective StudiesSpainColonoscopyColorectal cancerDiagnosisFaecal immunochemical testInterval cancerMortalityPopulation Screening ProgrammeSurvival

Identifiers

PMID28487610
PMCPMC5403752
OpenAlexW2606679901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.